Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Broad Spectrum of Human Natural Killer Cell Diversity
Aharon G. Freud, Bethany L. Mundy-Bosse, Jianhua Yu, et al.
Immunity (2017) Vol. 47, Iss. 5, pp. 820-833
Open Access | Times Cited: 576

Showing 1-25 of 576 citing articles:

NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu, Vasiliy Galat, Yekaterina Galat, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 491
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 468
Maternal Immunological Adaptation During Normal Pregnancy
Bahaa Abu-Raya, Christina Michalski, Manish Sadarangani, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 447
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier, Pierre Milpied, Bertrand Escalière, et al.
Immunity (2018) Vol. 49, Iss. 5, pp. 971-986.e5
Open Access | Times Cited: 398
Tumor-Infiltrating Natural Killer Cells
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 346
Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
Marco Colonna
Immunity (2018) Vol. 48, Iss. 6, pp. 1104-1117
Open Access | Times Cited: 337
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende, Michela Falco, Massimo Vitale, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 322
Tissue Determinants of Human NK Cell Development, Function, and Residence
Pranay Dogra, Chiara Rancan, Wenji Ma, et al.
Cell (2020) Vol. 180, Iss. 4, pp. 749-763.e13
Open Access | Times Cited: 322
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 299
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 292
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
Chao Yang, Jason Siebert, Robert Burns, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 240
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 183
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
Beatriz Sánchez-Correa, Isabel Valhondo, Fakhri Hassouneh, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 877-877
Open Access | Times Cited: 181
COVID-19 and Obesity: Dangerous Liaisons
Grazia Caci, Adriana Albini, Mario Malerba, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2511-2511
Open Access | Times Cited: 175
Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing
Samantha Smith, Philippa R Kennedy, Kevin Stacey, et al.
Blood Advances (2020) Vol. 4, Iss. 7, pp. 1388-1406
Open Access | Times Cited: 174
Subsets of ILC3−ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues
Marina Cella, Ramya Gamini, Cristiane Sécca, et al.
Nature Immunology (2019) Vol. 20, Iss. 8, pp. 980-991
Open Access | Times Cited: 170
Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
Samuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, et al.
Science Immunology (2021) Vol. 6, Iss. 62
Open Access | Times Cited: 156
A pan-cancer single-cell panorama of human natural killer cells
Fei Tang, Jinhu Li, Lu Qi, et al.
Cell (2023) Vol. 186, Iss. 19, pp. 4235-4251.e20
Open Access | Times Cited: 156
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
Weixiong Yang, Xiangbin Xing, Sai‐Ching J. Yeung, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003497-e003497
Open Access | Times Cited: 152
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Gaurav Nayyar, Yaya Chu, Mitchell S. Cairo
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 147
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 147
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 147
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yılmaz, Hanwei Cui, Michael A. Caligiuri, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 146
Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 136
Page 1 - Next Page

Scroll to top